Orionis Biosciences
PrivateLast Round
Corporate Funding
May 21, 2025
Total Funding Raised
$85.25M
Company Overview
Orionis Biosciences is a life sciences company focused on discovering conditionally active drug modalities for life-threatening diseases through innovative design concepts and technological advancements that enhance drug potency and precision.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Orionis Biosciences Comps
Public and private peers based on sector, stage, and business model.
Orionis Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | May 21, 2025 | ||||
| Corporate Funding | Sep 20, 2023 | ||||
| Series C | Oct 19, 2022 | ||||
| Convertible Debt | Mar 5, 2020 | ||||
| Series B | Apr 1, 2018 | ||||
Series A | Oct 5, 2015 |
Orionis Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cascade Investment | Series B |
| Genentech | Corporate Funding |
| V-Bio Ventures | Series A |
| Excel Venture Management | Series A |
| Cormorant Asset Management | Series C |
| AJU IB Investment | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 21, 2025
Second multi-year deal valued at over $2 billion for molecular glue development.
Orionis Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Orionis Biosciences's valuation, stock price, and market status.
